Literature DB >> 164484

Nature of the vagal inhibitory innervation to the lower esophageal sphincter.

R K Goyal, S Rattan.   

Abstract

The purpose of the present study was to investigate the nature of the vagal inhibitory innervation to the lower esophageal sphincter in the anesthetized opossum. Sphincter relaxation with electrical stimulation of the vagus was not antagonized by atropine, propranolol, phentolamine, or by catechloamine depletion with reserpine. A combination of atropine and propranolol was also ineffective, suggesting that the vagal inhibitory influences may be mediated by the noncholinergic, nonadrenergic neurons. To determine whether a synaptic link with nicotinic transmission was present, we investigated the effect of hexamethonium on vagal-stimulated lower esophageal sphincter relaxation. Hexamethonium in doses that completely antagonized the sphincter relaxation in response to a ganglionic stimulant, 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), did not block the sphincter relaxation in response to vagal stimulation at 10 pulses per second, and optimal frequency of stimulation. A combination of hexamethonium and catecholamine depletion was also ineffective, but hexamethonium plus atropine markedly antagonized sphincter relaxation (P less than 0.001). Moreover, 4-(m-chlorophenyl carbamoyloxy)-2-butyltrimethylammonium chloride (McN-A-343), a muscarinic ganglionic stimulant, also caused relaxation of the lower esophageal sphincter. We suggest from these results that: (a) pthe vagal inhibitory pathway to the sphincter consists of preganglionic fibers which synapse with postganglionic neurons: (b) the synaptic transmission is predominantly cholinergic and utilizes nicotinic as well as muscarinic receptors on the postganglionic neuron, and; (c) postganglionic neurons exert their influence on the sphincter by an unidentified inhibitory transmitter that is neither adrenergic nor cholinergic.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164484      PMCID: PMC301859          DOI: 10.1172/JCI108013

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves.

Authors:  P HOLTON
Journal:  J Physiol       Date:  1959-03-12       Impact factor: 5.182

2.  The cardiac sphincter in the cat.

Authors:  C G CLARK; J R VANE
Journal:  Gut       Date:  1961-09       Impact factor: 23.059

3.  Esophageal motility.

Authors:  F J INGELFINGER
Journal:  Physiol Rev       Date:  1958-10       Impact factor: 37.312

4.  Pharmacologic evidence for a cardiac sphincter mechanism in the cat.

Authors:  E A SCHENK; E L FREDERICKSON
Journal:  Gastroenterology       Date:  1961-01       Impact factor: 22.682

5.  The innervation of the cardia and lower oesophagus in man.

Authors:  F G ELLIS; R KAUNTZE; J R TROUNCE
Journal:  Br J Surg       Date:  1960-03       Impact factor: 6.939

Review 6.  On the mechanism of action of cyclic AMP and its role in synaptic transmission.

Authors:  P Greengard; D A McAfee; J W Kebabian
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

7.  Non-nicotinic transmission during ganglionic block with chlorisondamine and nicotine.

Authors:  K A Alkadhi; R J McIsaac
Journal:  Eur J Pharmacol       Date:  1973-10       Impact factor: 4.432

8.  Transmission of preganglionic impulses through the muscarinic receptors of the superior cervical ganglion of the cat.

Authors:  U Trendelenburg
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

9.  Mechanism of the lower esophageal sphincter relaxation. Action of prostaglandin E 1 and theophylline.

Authors:  R K Goyal; S Rattan
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

10.  Cardiac sympathetic adrenergic pathways in which synaptic transmission is blocked by atropine sulfate.

Authors:  A M Brown
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

View more
  31 in total

1.  Control of belching by the lower oesophageal sphincter.

Authors:  J B Wyman; J Dent; R Heddle; W J Dodds; J Toouli; J Downton
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

2.  Mechanism of stretch-activated excitatory and inhibitory responses in the lower esophageal sphincter.

Authors:  Yanfen Jiang; Valmik Bhargava; Ravinder K Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-11       Impact factor: 4.052

Review 3.  Physiology of normal esophageal motility.

Authors:  Raj K Goyal; Arun Chaudhury
Journal:  J Clin Gastroenterol       Date:  2008 May-Jun       Impact factor: 3.062

4.  High resolution manometry patterns distinguish acid sensitivity in non-cardiac chest pain.

Authors:  V M Kushnir; C Prakash Gyawali
Journal:  Neurogastroenterol Motil       Date:  2011-09-19       Impact factor: 3.598

Review 5.  Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.

Authors:  R Farré; D Sifrim
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

6.  Pathophysiology of gastroesophageal reflux.

Authors:  D B Skinner
Journal:  Ann Surg       Date:  1985-11       Impact factor: 12.969

7.  Physiology of esophageal sensorimotor malfunctions in neonatal neurological illness.

Authors:  Sudarshan R Jadcherla; Chin Yee Chan; Rebecca Moore; Soledad Fernandez; Reza Shaker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-17       Impact factor: 4.052

Review 8.  Structure activity relationship of synaptic and junctional neurotransmission.

Authors:  Raj K Goyal; Arun Chaudhury
Journal:  Auton Neurosci       Date:  2013-03-25       Impact factor: 3.145

9.  The role of the L-arginine-nitric oxide pathway in relaxation of the opossum lower oesophageal sphincter.

Authors:  A Tøttrup; M A Knudsen; H Gregersen
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

10.  The role of nitric oxide (NO) in 5-HT-induced relaxations of the guinea-pig stomach.

Authors:  A L Meulemans; L F Helsen; J A Schuurkes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.